Index by author
March 01, 2007; Volume 35,Issue 3
A
Ali, Shazia Y.
- You have accessUDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme KineticsZhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
Argikar, Upendra
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Ariyoshi, Noritaka
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Arkan, Melek C.
- You have accessDifferential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of CholestasisAndrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. CherringtonDrug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
Auerbach, Scott S.
- You have accessCAR2 Displays Unique Ligand Binding and RXRα Heterodimerization CharacteristicsScott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. OmiecinskiDrug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
B
Ban, Masaaki
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
Barbier, Olivier
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Bonzo, Jessica A.
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Bowalgaha, K.
- You have accessThe Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. MinersDrug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
Brace-Sinnokrak, Erin
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Bridges, Arlene S.
- You have accessIn Vitro and in Vivo Determination of Piperacillin Metabolism in HumansGiulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. BrouwerDrug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
Brouwer, Kim L. R.
- You have accessIn Vitro and in Vivo Determination of Piperacillin Metabolism in HumansGiulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. BrouwerDrug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
Bullock, Peter
- You have accessGlucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species DifferencesZhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
C
Cashman, John R.
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Chen, Shujuan
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Cherrington, Nathan J.
- You have accessDifferential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of CholestasisAndrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. CherringtonDrug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
Courtney, Paul
- You have accessThe Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery SettingCharles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. RileyDrug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
D
DeKeyser, Joshua G.
- You have accessCAR2 Displays Unique Ligand Binding and RXRα Heterodimerization CharacteristicsScott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. OmiecinskiDrug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
Djebli, Nassim
- You have accessMetabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre MarquetDrug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
Dupuis, Robert E.
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
E
Ekins, Sean
- You have accessClassification of Metabolites with Kernel-Partial Least Squares (K-PLS)Mark J. Embrechts and Sean EkinsDrug Metabolism and Disposition March 2007, 35 (3) 325-327; DOI: https://doi.org/10.1124/dmd.106.013185
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Elliot, D. J.
- You have accessThe Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. MinersDrug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
Embrechts, Mark J.
- You have accessClassification of Metabolites with Kernel-Partial Least Squares (K-PLS)Mark J. Embrechts and Sean EkinsDrug Metabolism and Disposition March 2007, 35 (3) 325-327; DOI: https://doi.org/10.1124/dmd.106.013185
Endo, Takuro
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
F
Fukami, Tatsuki
- You have accessCYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and TheophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi YokoiDrug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
G
Gaus, Hans J.
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Geary, Richard S.
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Generaux, Claudia N.
- You have accessIn Vitro and in Vivo Determination of Piperacillin Metabolism in HumansGiulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. BrouwerDrug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
Ghibellini, Giulia
- You have accessIn Vitro and in Vivo Determination of Piperacillin Metabolism in HumansGiulia Ghibellini, Arlene S. Bridges, Claudia N. Generaux and Kim L. R. BrouwerDrug Metabolism and Disposition March 2007, 35 (3) 345-349; DOI: https://doi.org/10.1124/dmd.106.012278
Grime, Ken
- You have accessThe Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery SettingCharles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. RileyDrug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
H
Haefeli, Walter Emil
- You have accessInhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil HaefeliDrug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
Hara, Yoshiki
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
Harwood, H. James
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Hata, Masayuki
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Hayashi, Yujiro
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
Hirata, Kazuma
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
Hirayama, Masamichi
- You have accessMechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory CytokinesTomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi TamaiDrug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
Hong, An
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Hoover, Dennis J.
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
I
Ishii, Itsuko
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
J
Jamei, Masoud
- You have accessMisuse of the Well-Stirred Model of Hepatic Drug ClearanceJiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. TuckerDrug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
Jie, Lu
- You have accessInhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious RatsXin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-XiangDrug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
K
Kaeding, Jenny
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Kalvass, J. Cory
- You have accessPharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and AntinociceptionJ. Cory Kalvass, Emily R. Olson and Gary M. PollackDrug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
Karin, Michael
- You have accessDifferential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of CholestasisAndrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. CherringtonDrug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
Kato, Yukio
- You have accessFunctional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira TsujiDrug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
Katoh, Miki
- You have accessCYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and TheophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi YokoiDrug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
Kazama, Emiko
- You have accessEffect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus MonkeysAkihito Ogasawara, Toshiyuki Kume and Emiko KazamaDrug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
Ketabi-Kiyanvash, Nahal
- You have accessInhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil HaefeliDrug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
Kim, Tae-Won
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Kitada, Mitsukazu
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Knights, K. M.
- You have accessThe Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. MinersDrug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
Kobayashi, Daisuke
- You have accessMechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory CytokinesTomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi TamaiDrug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
Komoriya, Kazumi
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
Kubo, Yoshiyuki
- You have accessFunctional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira TsujiDrug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
Kume, Toshiyuki
- You have accessEffect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus MonkeysAkihito Ogasawara, Toshiyuki Kume and Emiko KazamaDrug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
L
Lawton, Michael P.
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Lee, Kuo-Hsiung
- You have accessGlucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species DifferencesZhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
Lickteig, Andrew J.
- You have accessDifferential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of CholestasisAndrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. CherringtonDrug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
Lindahl, Ronald
- You have accessConstitutive and 3-Methylcholanthrene-Induced Rat ALDH3A1 Expression Is Mediated by Multiple Xenobiotic Response ElementsRichard Reisdorph and Ronald LindahlDrug Metabolism and Disposition March 2007, 35 (3) 386-393; DOI: https://doi.org/10.1124/dmd.106.012393
Lindenmaier, Heike
- You have accessInhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil HaefeliDrug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
M
Mackenzie, P. I.
- You have accessThe Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. MinersDrug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
Maeda, Tomoji
- You have accessMechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory CytokinesTomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi TamaiDrug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
Mankowski, Dayna C.
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Marquet, Pierre
- You have accessMetabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre MarquetDrug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
Martin, David E.
- You have accessGlucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species DifferencesZhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
Miles, Kristini K.
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
Miners, J. O.
- You have accessThe Glucuronidation of Δ4-3-Keto C19- and C21-Hydroxysteroids by Human Liver Microsomal and Recombinant UDP-glucuronosyltransferases (UGTs): 6α- and 21-Hydroxyprogesterone Are Selective Substrates for UGT2B7K. Bowalgaha, D. J. Elliot, P. I. Mackenzie, K. M. Knights and J. O. MinersDrug Metabolism and Disposition March 2007, 35 (3) 363-370; DOI: https://doi.org/10.1124/dmd.106.013052
Mitsuoka, Keisuke
- You have accessFunctional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira TsujiDrug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
Miyazawa, Keiji
- You have accessMechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory CytokinesTomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi TamaiDrug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
Momose, Yasunori
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
Murayama, Norie
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
N
Nagashima, Satomi
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Nakajima, Miki
- You have accessCYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and TheophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi YokoiDrug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
Nakamura, Hiroyoshi
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Nishigaki, Ryuichiro
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
O
O'Donnell, Charles J.
- You have accessThe Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery SettingCharles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. RileyDrug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
Ogasawara, Akihito
- You have accessEffect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus MonkeysAkihito Ogasawara, Toshiyuki Kume and Emiko KazamaDrug Metabolism and Disposition March 2007, 35 (3) 410-418; DOI: https://doi.org/10.1124/dmd.106.011288
Ohmori, Shigeru
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Ohsuye, Kazuhiro
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
Olson, Emily R.
- You have accessPharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and AntinociceptionJ. Cory Kalvass, Emily R. Olson and Gary M. PollackDrug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
Omiecinski, Curtis J.
- You have accessCAR2 Displays Unique Ligand Binding and RXRα Heterodimerization CharacteristicsScott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. OmiecinskiDrug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
P
Picard, Nicolas
- You have accessMetabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre MarquetDrug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
Pollack, Gary M.
- You have accessPharmacokinetics and Pharmacodynamics of Alfentanil in P-Glycoprotein-Competent and P-Glycoprotein-Deficient Mice: P-Glycoprotein Efflux Alters Alfentanil Brain Disposition and AntinociceptionJ. Cory Kalvass, Emily R. Olson and Gary M. PollackDrug Metabolism and Disposition March 2007, 35 (3) 455-459; DOI: https://doi.org/10.1124/dmd.106.011445
R
Reisdorph, Richard
- You have accessConstitutive and 3-Methylcholanthrene-Induced Rat ALDH3A1 Expression Is Mediated by Multiple Xenobiotic Response ElementsRichard Reisdorph and Ronald LindahlDrug Metabolism and Disposition March 2007, 35 (3) 386-393; DOI: https://doi.org/10.1124/dmd.106.012393
Remmel, Rory P.
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Riley, Robert J.
- You have accessThe Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery SettingCharles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. RileyDrug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
Ritter, Joseph K.
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
Rostami-Hodjegan, Amin
- You have accessMisuse of the Well-Stirred Model of Hepatic Drug ClearanceJiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. TuckerDrug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
S
Sakai, Haruko
- You have accessCYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and TheophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi YokoiDrug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
Sauvage, François-Ludovic
- You have accessMetabolism of Sirolimus in the Presence or Absence of Cyclosporine by Genotyped Human Liver Microsomes and Recombinant Cytochromes P450 3A4 and 3A5Nicolas Picard, Nassim Djebli, François-Ludovic Sauvage and Pierre MarquetDrug Metabolism and Disposition March 2007, 35 (3) 350-355; DOI: https://doi.org/10.1124/dmd.106.012161
Senekeo-Effenberger, Kathy
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Shimizu, Makiko
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Shimomura, Hitoshi
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Slee, Dean
- You have accessThe Development of a Cocktail CYP2B6, CYP2C8, and CYP3A5 Inhibition Assay and a Preliminary Assessment of Utility in a Drug Discovery SettingCharles J. O'Donnell, Ken Grime, Paul Courtney, Dean Slee and Robert J. RileyDrug Metabolism and Disposition March 2007, 35 (3) 381-385; DOI: https://doi.org/10.1124/dmd.106.012344
Slitt, Angela L.
- You have accessDifferential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-α, Interleukin-1β, Interleukin-6, and Nuclear Factor-κB in Two Models of CholestasisAndrew J. Lickteig, Angela L. Slitt, Melek C. Arkan, Michael Karin and Nathan J. CherringtonDrug Metabolism and Disposition March 2007, 35 (3) 402-409; DOI: https://doi.org/10.1124/dmd.106.012138
Smith, Philip C.
- You have accessUDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme KineticsZhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
- You have accessGlucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species DifferencesZhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
Stern, Stephan T.
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
Stoner, Matthew A.
- You have accessCAR2 Displays Unique Ligand Binding and RXRα Heterodimerization CharacteristicsScott S. Auerbach, Joshua G. DeKeyser, Matthew A. Stoner and Curtis J. OmiecinskiDrug Metabolism and Disposition March 2007, 35 (3) 428-439; DOI: https://doi.org/10.1124/dmd.106.012641
Sugiyama, Yuichi
- You have accessCharacterization of the Hepatic Disposition of Lanoteplase, a Rationally Designed Variant of Tissue Plasminogen Activator in RodentsKazumi Komoriya, Yukio Kato, Yujiro Hayashi, Kazuhiro Ohsuye, Ryuichiro Nishigaki and Yuichi SugiyamaDrug Metabolism and Disposition March 2007, 35 (3) 469-475; DOI: https://doi.org/10.1124/dmd.106.012518
T
Tallman, Melanie N.
- You have accessUDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme KineticsZhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
- You have accessGender-Related Differences in Mycophenolate Mofetil-Induced Gastrointestinal Toxicity in RatsStephan T. Stern, Melanie N. Tallman, Kristini K. Miles, Joseph K. Ritter, Robert E. Dupuis and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 449-454; DOI: https://doi.org/10.1124/dmd.106.012013
Tamai, Ikumi
- You have accessMechanism of the Regulation of Organic Cation/Carnitine Transporter 1 (SLC22A4) by Rheumatoid Arthritis-Associated Transcriptional Factor RUNX1 and Inflammatory CytokinesTomoji Maeda, Masamichi Hirayama, Daisuke Kobayashi, Keiji Miyazawa and Ikumi TamaiDrug Metabolism and Disposition March 2007, 35 (3) 394-401; DOI: https://doi.org/10.1124/dmd.106.012112
Tanaka, Kanako
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Theile, Dirk
- You have accessInhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil HaefeliDrug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
Torimoto, Nao
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Toyama, Ken-Ichi
- You have accessHelices F–G Are Important for the Substrate Specificities of CYP3A7Nao Torimoto, Itsuko Ishii, Ken-Ichi Toyama, Masayuki Hata, Kanako Tanaka, Hitoshi Shimomura, Hiroyoshi Nakamura, Noritaka Ariyoshi, Shigeru Ohmori and Mitsukazu KitadaDrug Metabolism and Disposition March 2007, 35 (3) 484-492; DOI: https://doi.org/10.1124/dmd.106.011304
Treadway, Judith L.
- You have accessThree-Dimensional Quantitative Structure-Activity Relationship Analysis of Human CYP51 InhibitorsSean Ekins, Dayna C. Mankowski, Dennis J. Hoover, Michael P. Lawton, Judith L. Treadway and H. James HarwoodDrug Metabolism and Disposition March 2007, 35 (3) 493-500; DOI: https://doi.org/10.1124/dmd.106.013888
Trottier, Jocelyn
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Tsuji, Akira
- You have accessFunctional Expression of Stereoselective Metabolism of Cephalexin by Exogenous Transfection of Oligopeptide Transporter PEPT1Keisuke Mitsuoka, Yukio Kato, Yoshiyuki Kubo and Akira TsujiDrug Metabolism and Disposition March 2007, 35 (3) 356-362; DOI: https://doi.org/10.1124/dmd.106.010405
Tucker, Geoffrey T.
- You have accessMisuse of the Well-Stirred Model of Hepatic Drug ClearanceJiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. TuckerDrug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
Tukey, Robert H.
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
W
Watanabe, Tanya A.
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Weiss, Johanna
- You have accessInhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase InhibitorsJohanna Weiss, Dirk Theile, Nahal Ketabi-Kiyanvash, Heike Lindenmaier and Walter Emil HaefeliDrug Metabolism and Disposition March 2007, 35 (3) 340-344; DOI: https://doi.org/10.1124/dmd.106.012765
Wen, Zhiming
- You have accessUDP-Glucuronosyltransferase 1A1 Is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme KineticsZhiming Wen, Melanie N. Tallman, Shazia Y. Ali and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 371-380; DOI: https://doi.org/10.1124/dmd.106.012732
- You have accessGlucuronidation of Anti-HIV Drug Candidate Bevirimat: Identification of Human UDP-glucuronosyltransferases and Species DifferencesZhiming Wen, David E. Martin, Peter Bullock, Kuo-Hsiung Lee and Philip C. SmithDrug Metabolism and Disposition March 2007, 35 (3) 440-448; DOI: https://doi.org/10.1124/dmd.106.012815
X
Xiang-Jun, Zhou
- You have accessInhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious RatsXin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-XiangDrug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
Y
Yamamoto, Akitoshi
- You have accessInvolvement of CYP2A6 in the Formation of a Novel Metabolite, 3-Hydroxypilocarpine, from Pilocarpine in Human Liver MicrosomesTakuro Endo, Masaaki Ban, Kazuma Hirata, Akitoshi Yamamoto, Yoshiki Hara and Yasunori MomoseDrug Metabolism and Disposition March 2007, 35 (3) 476-483; DOI: https://doi.org/10.1124/dmd.106.013425
Yamazaki, Hiroshi
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Yan-Fei, Xin
- You have accessInhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious RatsXin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-XiangDrug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
Yang, Jiansong
- You have accessMisuse of the Well-Stirred Model of Hepatic Drug ClearanceJiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. TuckerDrug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
Yano, Hiroshi
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
Yeo, Karen R.
- You have accessMisuse of the Well-Stirred Model of Hepatic Drug ClearanceJiansong Yang, Masoud Jamei, Karen R. Yeo, Amin Rostami-Hodjegan and Geoffrey T. TuckerDrug Metabolism and Disposition March 2007, 35 (3) 501-502; DOI: https://doi.org/10.1124/dmd.106.013359
Yokoi, Tsuyoshi
- You have accessCYP2A13 Metabolizes the Substrates of Human CYP1A2, Phenacetin, and TheophyllineTatsuki Fukami, Miki Nakajima, Haruko Sakai, Miki Katoh and Tsuyoshi YokoiDrug Metabolism and Disposition March 2007, 35 (3) 335-339; DOI: https://doi.org/10.1124/dmd.106.011064
Yong-Xiang, Wang
- You have accessInhibitory Effects of Benzoate on Chiral Inversion and Clearance of NG-Nitro-Arginine in Conscious RatsXin Yan-Fei, Zhou Xiang-Jun, Lu Jie and Wang Yong-XiangDrug Metabolism and Disposition March 2007, 35 (3) 331-334; DOI: https://doi.org/10.1124/dmd.106.011429
Yu, Rosie Z.
- You have accessCross-Species Pharmacokinetic Comparison from Mouse to Man of a Second-Generation Antisense Oligonucleotide, ISIS 301012, Targeting Human Apolipoprotein B-100Rosie Z. Yu, Tae-Won Kim, An Hong, Tanya A. Watanabe, Hans J. Gaus and Richard S. GearyDrug Metabolism and Disposition March 2007, 35 (3) 460-468; DOI: https://doi.org/10.1124/dmd.106.012401
Yueh, Mei-Fei
- You have accessExpression of the Human UGT1 Locus in Transgenic Mice by 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic Acid (WY-14643) and Implications on Drug Metabolism through Peroxisome Proliferator-Activated Receptor α ActivationKathy Senekeo-Effenberger, Shujuan Chen, Erin Brace-Sinnokrak, Jessica A. Bonzo, Mei-Fei Yueh, Upendra Argikar, Jenny Kaeding, Jocelyn Trottier, Rory P. Remmel, Joseph K. Ritter, Olivier Barbier and Robert H. TukeyDrug Metabolism and Disposition March 2007, 35 (3) 419-427; DOI: https://doi.org/10.1124/dmd.106.013243
Z
Zhang, Jun
- You have accessEffect of Genetic Variants of the Human Flavin-Containing Monooxygenase 3 on N- and S-Oxygenation ActivitiesMakiko Shimizu, Hiroshi Yano, Satomi Nagashima, Norie Murayama, Jun Zhang, John R. Cashman and Hiroshi YamazakiDrug Metabolism and Disposition March 2007, 35 (3) 328-330; DOI: https://doi.org/10.1124/dmd.106.013094
In this issue
Advertisement